Skip to main content

Table 1 Focus Group participant demographics, breast cancer risk, N = 32

From: Awareness of preventive medication among women at high risk for breast cancer and their willingness to consider transdermal or oral tamoxifen: a focus group study

Characteristic

 

Mean Age

48 (25–67)

Education

 Some High School

2 (6 %)

 Some College

5 (16 %)

 College Degree

11 (34 %)

 Graduate Degree

14 (44 %)

Ancestry

 

 European

16 (50 %)

 African

10 (31 %)

 Other

6 (19 %)

Ethnicity

 Hispanic

4 (13 %)

 Non-Hispanic

28 (87 %)

Mean Age of Menarche

12 (9–17)

Mean Age at 1st Live Birth

29 (16–39)

1st or 2nd Degree Female Relative with Breast Cancer

21 (66 %)

History of Breast Biopsy

16 (50 %)

History of Biopsy with Atypia

3 (9 %)

BRCA 1/2 Mutation Carrier

0 (0 %)

BIRADS Mammographic Density

 0 – No Mammogram

3 (9 %)

 1 – Fatty

1 (3 %)

 2 – Scattered Fibroglandular

9 (28 %)

 3 – Heterogeneously Dense

19 (60 %)

 4 – Extremely Dense

0 (0 %)

Prior Knowledge of Preventive Medicines

6 (19 %)

MD Recommended Preventive Medicine

2 (6 %)

Estimated Breast Cancer Risk (Gail Model)

 Above Peer Average

23 (72 %)

 At Peer Average

3 (9 %)

 Below Peer Average

6 (19 %)